[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pneumococcal Vaccine Market - Global Outlook and Forecast 2021-2027

March 2021 | 91 pages | ID: P5473750DC4EEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Pneumococcal Vaccine in global, including the following market information:

Global Pneumococcal Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Pneumococcal Vaccine Market Sales, 2016-2021, 2022-2027, (K Doses)

Global top five Pneumococcal Vaccine companies in 2020 (%)

The global Pneumococcal Vaccine market was valued at 8211 million in 2020 and is projected to reach US$ 8562.3 million by 2027, at a CAGR of 1.1% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pneumococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pneumococcal Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Doses)

Global Pneumococcal Vaccine Market Segment Percentages, By Type, 2020 (%)
  • PPSV 23
  • PCV 7/13
  • PCV 10
Global Pneumococcal Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Doses)

Global Pneumococcal Vaccine Market Segment Percentages, By Application, 2020 (%)
  • Child
  • Adult
Global Pneumococcal Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Doses)

Global Pneumococcal Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pneumococcal Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Pneumococcal Vaccine revenues share in global market, 2020 (%)

Key companies Pneumococcal Vaccine sales in global market, 2016-2021 (Estimated), (K Doses)

Key companies Pneumococcal Vaccine sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Pfizer
  • GSK
  • MSD
  • Sanofipasteur
  • CDIBP
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pneumococcal Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by End User
1.3 Global Pneumococcal Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PNEUMOCOCCAL VACCINE OVERALL MARKET SIZE

2.1 Global Pneumococcal Vaccine Market Size: 2021 VS 2027
2.2 Global Pneumococcal Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Pneumococcal Vaccine Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Pneumococcal Vaccine Players in Global Market
3.2 Top Global Pneumococcal Vaccine Companies Ranked by Revenue
3.3 Global Pneumococcal Vaccine Revenue by Companies
3.4 Global Pneumococcal Vaccine Sales by Companies
3.5 Global Pneumococcal Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pneumococcal Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Pneumococcal Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pneumococcal Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Pneumococcal Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Pneumococcal Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Pneumococcal Vaccine Market Size Markets, 2021 & 2027
  4.1.2 PPSV
  4.1.3 PCV 7/13
  4.1.4 PCV
4.2 By Type - Global Pneumococcal Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Pneumococcal Vaccine Revenue, 2016-2021
  4.2.2 By Type - Global Pneumococcal Vaccine Revenue, 2022-2027
  4.2.3 By Type - Global Pneumococcal Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Pneumococcal Vaccine Sales & Forecasts
  4.3.1 By Type - Global Pneumococcal Vaccine Sales, 2016-2021
  4.3.2 By Type - Global Pneumococcal Vaccine Sales, 2022-2027
  4.3.3 By Type - Global Pneumococcal Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Pneumococcal Vaccine Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pneumococcal Vaccine Market Size, 2021 & 2027
  5.1.2 Child
  5.1.3 Adult
5.2 By Application - Global Pneumococcal Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Pneumococcal Vaccine Revenue, 2016-2021
  5.2.2 By Application - Global Pneumococcal Vaccine Revenue, 2022-2027
  5.2.3 By Application - Global Pneumococcal Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Pneumococcal Vaccine Sales & Forecasts
  5.3.1 By Application - Global Pneumococcal Vaccine Sales, 2016-2021
  5.3.2 By Application - Global Pneumococcal Vaccine Sales, 2022-2027
  5.3.3 By Application - Global Pneumococcal Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Pneumococcal Vaccine Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Pneumococcal Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Pneumococcal Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Pneumococcal Vaccine Revenue, 2016-2021
  6.2.2 By Region - Global Pneumococcal Vaccine Revenue, 2022-2027
  6.2.3 By Region - Global Pneumococcal Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Pneumococcal Vaccine Sales & Forecasts
  6.3.1 By Region - Global Pneumococcal Vaccine Sales, 2016-2021
  6.3.2 By Region - Global Pneumococcal Vaccine Sales, 2022-2027
  6.3.3 By Region - Global Pneumococcal Vaccine Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Pneumococcal Vaccine Revenue, 2016-2027
  6.4.2 By Country - North America Pneumococcal Vaccine Sales, 2016-2027
  6.4.3 US Pneumococcal Vaccine Market Size, 2016-2027
  6.4.4 Canada Pneumococcal Vaccine Market Size, 2016-2027
  6.4.5 Mexico Pneumococcal Vaccine Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Pneumococcal Vaccine Revenue, 2016-2027
  6.5.2 By Country - Europe Pneumococcal Vaccine Sales, 2016-2027
  6.5.3 Germany Pneumococcal Vaccine Market Size, 2016-2027
  6.5.4 France Pneumococcal Vaccine Market Size, 2016-2027
  6.5.5 U.K. Pneumococcal Vaccine Market Size, 2016-2027
  6.5.6 Italy Pneumococcal Vaccine Market Size, 2016-2027
  6.5.7 Russia Pneumococcal Vaccine Market Size, 2016-2027
  6.5.8 Nordic Countries Pneumococcal Vaccine Market Size, 2016-2027
  6.5.9 Benelux Pneumococcal Vaccine Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Pneumococcal Vaccine Revenue, 2016-2027
  6.6.2 By Region - Asia Pneumococcal Vaccine Sales, 2016-2027
  6.6.3 China Pneumococcal Vaccine Market Size, 2016-2027
  6.6.4 Japan Pneumococcal Vaccine Market Size, 2016-2027
  6.6.5 South Korea Pneumococcal Vaccine Market Size, 2016-2027
  6.6.6 Southeast Asia Pneumococcal Vaccine Market Size, 2016-2027
  6.6.7 India Pneumococcal Vaccine Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Pneumococcal Vaccine Revenue, 2016-2027
  6.7.2 By Country - South America Pneumococcal Vaccine Sales, 2016-2027
  6.7.3 Brazil Pneumococcal Vaccine Market Size, 2016-2027
  6.7.4 Argentina Pneumococcal Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Pneumococcal Vaccine Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Pneumococcal Vaccine Sales, 2016-2027
  6.8.3 Turkey Pneumococcal Vaccine Market Size, 2016-2027
  6.8.4 Israel Pneumococcal Vaccine Market Size, 2016-2027
  6.8.5 Saudi Arabia Pneumococcal Vaccine Market Size, 2016-2027
  6.8.6 UAE Pneumococcal Vaccine Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Pneumococcal Vaccine Major Product Offerings
  7.1.4 Pfizer Pneumococcal Vaccine Sales and Revenue in Global (2016-2021)
  7.1.5 Pfizer Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Pneumococcal Vaccine Major Product Offerings
  7.2.4 GSK Pneumococcal Vaccine Sales and Revenue in Global (2016-2021)
  7.2.5 GSK Key News
7.3 MSD
  7.3.1 MSD Corporate Summary
  7.3.2 MSD Business Overview
  7.3.3 MSD Pneumococcal Vaccine Major Product Offerings
  7.3.4 MSD Pneumococcal Vaccine Sales and Revenue in Global (2016-2021)
  7.3.5 MSD Key News
7.4 Sanofipasteur
  7.4.1 Sanofipasteur Corporate Summary
  7.4.2 Sanofipasteur Business Overview
  7.4.3 Sanofipasteur Pneumococcal Vaccine Major Product Offerings
  7.4.4 Sanofipasteur Pneumococcal Vaccine Sales and Revenue in Global (2016-2021)
  7.4.5 Sanofipasteur Key News
7.5 CDIBP
  7.5.1 CDIBP Corporate Summary
  7.5.2 CDIBP Business Overview
  7.5.3 CDIBP Pneumococcal Vaccine Major Product Offerings
  7.5.4 CDIBP Pneumococcal Vaccine Sales and Revenue in Global (2016-2021)
  7.5.5 CDIBP Key News

8 GLOBAL PNEUMOCOCCAL VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Pneumococcal Vaccine Production Capacity, 2016-2027
8.2 Pneumococcal Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pneumococcal Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 PNEUMOCOCCAL VACCINE SUPPLY CHAIN ANALYSIS

10.1 Pneumococcal Vaccine Industry Value Chain
10.2 Pneumococcal Vaccine Upstream Market
10.3 Pneumococcal Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Pneumococcal Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Pneumococcal Vaccine in Global Market
Table 2. Top Pneumococcal Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Pneumococcal Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Pneumococcal Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global Pneumococcal Vaccine Sales by Companies, (K Doses), 2016-2021
Table 6. Global Pneumococcal Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pneumococcal Vaccine Price (2016-2021) & (USD/Dose)
Table 8. Global Manufacturers Pneumococcal Vaccine Product Type
Table 9. List of Global Tier 1 Pneumococcal Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumococcal Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Pneumococcal Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Pneumococcal Vaccine Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Pneumococcal Vaccine Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Pneumococcal Vaccine Sales (K Doses), 2016-2021
Table 15. By Type - Global Pneumococcal Vaccine Sales (K Doses), 2022-2027
Table 16. By Application – Global Pneumococcal Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Pneumococcal Vaccine Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Pneumococcal Vaccine Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Pneumococcal Vaccine Sales (K Doses), 2016-2021
Table 20. By Application - Global Pneumococcal Vaccine Sales (K Doses), 2022-2027
Table 21. By Region – Global Pneumococcal Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Pneumococcal Vaccine Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Pneumococcal Vaccine Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Pneumococcal Vaccine Sales (K Doses), 2016-2021
Table 25. By Region - Global Pneumococcal Vaccine Sales (K Doses), 2022-2027
Table 26. By Country - North America Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Pneumococcal Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Pneumococcal Vaccine Sales, (K Doses), 2016-2021
Table 29. By Country - North America Pneumococcal Vaccine Sales, (K Doses), 2022-2027
Table 30. By Country - Europe Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Pneumococcal Vaccine Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Pneumococcal Vaccine Sales, (K Doses), 2016-2021
Table 33. By Country - Europe Pneumococcal Vaccine Sales, (K Doses), 2022-2027
Table 34. By Region - Asia Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Pneumococcal Vaccine Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Pneumococcal Vaccine Sales, (K Doses), 2016-2021
Table 37. By Region - Asia Pneumococcal Vaccine Sales, (K Doses), 2022-2027
Table 38. By Country - South America Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Pneumococcal Vaccine Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Pneumococcal Vaccine Sales, (K Doses), 2016-2021
Table 41. By Country - South America Pneumococcal Vaccine Sales, (K Doses), 2022-2027
Table 42. By Country - Middle East & Africa Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Pneumococcal Vaccine Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Pneumococcal Vaccine Sales, (K Doses), 2016-2021
Table 45. By Country - Middle East & Africa Pneumococcal Vaccine Sales, (K Doses), 2022-2027
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Pneumococcal Vaccine Product Offerings
Table 48. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 49. GSK Corporate Summary
Table 50. GSK Pneumococcal Vaccine Product Offerings
Table 51. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 52. MSD Corporate Summary
Table 53. MSD Pneumococcal Vaccine Product Offerings
Table 54. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 55. Sanofipasteur Corporate Summary
Table 56. Sanofipasteur Pneumococcal Vaccine Product Offerings
Table 57. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 58. CDIBP Corporate Summary
Table 59. CDIBP Pneumococcal Vaccine Product Offerings
Table 60. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 61. Pneumococcal Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2019-2021 (K Doses)
Table 62. Global Pneumococcal Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 63. Global Pneumococcal Vaccine Production by Region, 2016-2021 (K Doses)
Table 64. Global Pneumococcal Vaccine Production by Region, 2022-2027 (K Doses)
Table 65. Pneumococcal Vaccine Market Opportunities & Trends in Global Market
Table 66. Pneumococcal Vaccine Market Drivers in Global Market
Table 67. Pneumococcal Vaccine Market Restraints in Global Market
Table 68. Pneumococcal Vaccine Raw Materials
Table 69. Pneumococcal Vaccine Raw Materials Suppliers in Global Market
Table 70. Typical Pneumococcal Vaccine Downstream
Table 71. Pneumococcal Vaccine Downstream Clients in Global Market
Table 72. Pneumococcal Vaccine Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Pneumococcal Vaccine Segment by Type
Figure 2. Pneumococcal Vaccine Segment by Application
Figure 3. Global Pneumococcal Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pneumococcal Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pneumococcal Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Pneumococcal Vaccine Sales in Global Market: 2016-2027 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pneumococcal Vaccine Revenue in 2020
Figure 9. By Type - Global Pneumococcal Vaccine Sales Market Share, 2016-2027
Figure 10. By Type - Global Pneumococcal Vaccine Revenue Market Share, 2016-2027
Figure 11. By Type - Global Pneumococcal Vaccine Price (USD/Dose), 2016-2027
Figure 12. By Application - Global Pneumococcal Vaccine Sales Market Share, 2016-2027
Figure 13. By Application - Global Pneumococcal Vaccine Revenue Market Share, 2016-2027
Figure 14. By Application - Global Pneumococcal Vaccine Price (USD/Dose), 2016-2027
Figure 15. By Region - Global Pneumococcal Vaccine Sales Market Share, 2016-2027
Figure 16. By Region - Global Pneumococcal Vaccine Revenue Market Share, 2016-2027
Figure 17. By Country - North America Pneumococcal Vaccine Revenue Market Share, 2016-2027
Figure 18. By Country - North America Pneumococcal Vaccine Sales Market Share, 2016-2027
Figure 19. US Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Pneumococcal Vaccine Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Pneumococcal Vaccine Sales Market Share, 2016-2027
Figure 24. Germany Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. France Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Pneumococcal Vaccine Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Pneumococcal Vaccine Sales Market Share, 2016-2027
Figure 33. China Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. India Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Pneumococcal Vaccine Revenue Market Share, 2016-2027
Figure 39. By Country - South America Pneumococcal Vaccine Sales Market Share, 2016-2027
Figure 40. Brazil Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Pneumococcal Vaccine Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Pneumococcal Vaccine Sales Market Share, 2016-2027
Figure 44. Turkey Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Pneumococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 48. Global Pneumococcal Vaccine Production Capacity (K Doses), 2016-2027
Figure 49. The Percentage of Production Pneumococcal Vaccine by Region, 2020 VS 2027
Figure 50. Pneumococcal Vaccine Industry Value Chain
Figure 51. Marketing Channels


More Publications